AFE has partnered with Athira Pharma for outreach on new clinical trials for ATH-1017, an investigational treatment for Alzheimer’s Disease. In this segment, Dr. David Greeley, MD, FAAN, founder of Northwest Neurological, focuses on the details of clinical trials and what they mean for you and your family. Northwest Neurological in Spokane, Washington provides medical services to patients with neurological concerns…

Read More

In this segment sponsored by Athira Pharma, Suzanne speaks with  Dr. Charles Bernick, MD, MPH, a clinical professor at the University of Washington Department of Neurology who has researched Alzheimer’s Disease and treatments for 25 years. He is Director of Clinical Trials for the Memory & Brain Wellness Clinic and a co-investigator at the Alzheimer’s Disease Research Center.

Read More

By: Suzanne Newman from Answers for Elders — If you have a loved one or friend who has Alzheimer’s disease you may be interested in a brand-new cutting edge clinical study being conducted by Athira Pharma. Athira is a biopharmaceutical company focused on developing therapies to restore neuronal health and stop neurodegeneration. The company’s goal is…

Read More

by: Melody Gonzales — PORTLAND, Ore. (KOIN) — In the US, more than 6 million people are living with Alzheimer’s disease, and that number is expected to more than double by 2050. Sara Salezberg was just 55 when she was diagnosed with Alzheimer’s disease in 2015. “Something just happened to my brain like… I had no clue…

Read More